QBTS — Deep Dive

Deep Dive Ticker Tape

Article published Jun 28, 2026. Prices below use latest available snapshots.

QBTS Price Structure

↗
Loading chart…

Loading timeframes…

Thesis: Annealing commercial leader: record Q1 bookings (~33M), 100+ customers, a peer-reviewed useful-supremacy result — the one quantum name with an actual business — but lumpy revenue, big losses, and heavy insider selling into a drawdown; the survivor to watch first

Verdict: Research-only / watch, not a buy. This is a primary-source pass on D-Wave for a wider quantum-compute deep-dive program. QBTS earns a distinct tag the rest of the basket has not: it is the one quantum name with an actual commercial business — real bookings, real customers, real production workloads. That earns "the survivor to watch first" — not a perspective, not a trend-hold entry, and not a claim that D-Wave is ahead on general-purpose quantum computing. The house view on quantum stays skeptical-but-watching; QBTS is simply where we'd look first when it's time to look.

The Story Right Now

D-Wave is the quantum name that already sells something. While IONQ, RGTI, QUBT and the rest of our quantum-computing universe are effectively pre-revenue science projects, QBTS booked record Q1'26 bookings of $33.4M (up ~2,000% YoY) — a $20M Advantage2 system sale to Florida Atlantic University plus a $10M, two-year quantum-computing-as-a-service contract with a Fortune 100 customer. It reports 100+ customers in Q1'26 (>50% commercial enterprises), 100+ organizations running production workloads with measurable ROI across manufacturing, logistics, public safety and pharma, and customer usage +314% YoY. That is a commercial business, not a slide deck. It's the entire reason this name gets the "survivor" tag.

But say the important thing plainly: D-Wave is an annealing company — optimization and sampling — not universal gate-model quantum computing. Its commercial traction is real, but it lives in a narrower niche than the fault-tolerant, general-purpose machine the sector's biggest valuations are pricing. "Furthest along commercially" does not mean "ahead on general quantum computing." It means D-Wave found a real, paying corner of the problem space early and is monetizing it while the gate-model crowd is still pre-product. Those are different races; QBTS leads one of them, and it isn't the one most people mean when they say "quantum."

The numbers underneath are messy, and you have to read them in the right order. Revenue is lumpy — FY2025 was $24.6M, but Q1'26 product revenue was only $2.9M (YoY −81%), a swing driven entirely by system-sale timing, not a demand collapse (the demand signal is the $33.4M of bookings, which convert later). Losses are big: FY2025 operating loss −$100.4M, Q1'26 operating loss −$54.7M, with operating cash burn of $72M/yr. Ignore the headline net-income line — a positive net swing here is warrant/derivative mark-to-market noise, not operating profit; anchor on the operating loss, the burn, and the bookings. The balance sheet is the thing that buys time: **$588M of total liquidity** ($338.2M cash & equivalents + $250.2M short-term investments) at Q1'26.

The tape says wait. QBTS is $22.76, down −16.51% over the trailing 30 sessions (range $20.93–$31.30) — a drawdown, not the bottom→pop→flag→breakout setup our book actually buys. And the insider signal is loud: 1 buy / 56 sells, net −$331.1M — heavy distribution into that drawdown. Real business, real customers, real first-mover commercial lead in annealing — and still not a buy today. Lumpy revenue, large losses, insiders selling hard, tape bleeding. The fundamentals say "watch this one first"; the chart and the insiders say "not yet."

Extended analysis